- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
NOCIL reported Q3FY26 revenue of 316 Cr, a slight 1% dip QoQ, with 9MFY26 revenue at 973 Cr, down 8% YoY. Net profit for Q3 stood at 9 Cr (-24% QoQ), and 39 Cr for 9MFY26 (-53% YoY). Despite ongoing market challenges and dumping pressure, volumes are trending up, with full-year volume growth projected at 3-4%. Q3 Operating EBITDA improved to 27 Cr (+20% QoQ), boosting margins to 8.5%.
The company is driving sustainable growth through Green Chemistry and Responsible Care. A key strategic focus is the Rs. 250 Cr Dahej plant expansion, which is ahead of schedule, signaling strong future demand. NOCIL aims to double its market share across Asia, Europe, and the US. It's well-positioned to benefit from the global "China +1" sourcing shift, leveraging its reliable, non-Chinese manufacturing capacity and balanced price-volume strategy in a challenging market.